STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

NVAX NOVAVAX INCORPORATED StockScouter® Report

6

StockScouter® Score

NOVAVAX INCORPORATED, a small cap value company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • Moving average analysis for NVAX suggests weak price movement over the medium term. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

D
C
A
C

Previous Ratings

6
9
5